Viral immunologyHumansCOVID-19SARS-CoV-2GranulocytesCOVID-19 Drug Treatment
COVID-19: Understanding the Granulocyte Response and Exploring Their Therapeutic Interventions.
Zahra Farjami, Mina Moradi, Neshat Ebrahimi, Mohammad Mehdi Akbarin
Published: 202510.1177/08828245251391816
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has led to a global health crisis by triggering extensive systemic and immune dysregulation. Granulocytes, including neutrophils…
Preview only. Read the full abstract at the source